Dr Gibson on Current and Emerging Biomarkers in Gastric/GEJ

Michael K. Gibson MD, PhD, discusses current and emerging biomarkers in the treatment of patients with gastric or gastroesophageal junction adenocarcinoma.

Related Keywords

, Michaelk Gibson , Vanderbilt Health , Vanderbilt Ingram Cancer Center , Gibson , Translational Research In Head , Translational Research , Neck Oncology , Science Summit , Onclive Tv , Gastrointestinal Cancer ,